Soluble Epidermal Growth Factor Receptor: A Biomarker of Epithelial Ovarian Cancer
Soluble Epidermal Growth Factor Receptor: A Biomarker of Epithelial Ovarian Cancer
复制标题
DOI:
10.1007/978-0-387-98094-2_9
复制
发表时间:
2009-01-01
期刊:
影响因子:
--
通讯作者:
Maihle, Nita J.
中科院分区:
文献类型:
--
作者:
Baron, Andre T.;Lafky, Jacqueline M.;Maihle, Nita J.
The epidermal growth factor receptor (EGFR) is the prototypic member of the ErbB receptor tyrosine kinase family, which includes ErbB1 (EGFR), ErbB2 (HER2, Neu), ErbB3 (HER3), and ErbB4 (HER4). 1–3 Biochemical and structural studies show that the mature form of EGFR is a 170-kDa plasma membrane protein that is composed of extracellular, transmembrane-spanning, and intracellular domains. 4 The extracellular domain is divided into four subdomains: subdomains I and III function in growth factor binding, and subdomains II and IV confer secondary and tertiary structure to the extracellular domain through cysteine residues. The intracellular domain also is divided into subdomains: a tyrosine kinase subdomain and a carboxy-terminal regulatory subdomain that includes several tyrosine autophosphorylation sites. In general, growth factor binding to EGFR results in receptor dimerization with any member of the ErbB receptor family, transphosphorylation of tyrosine residues, docking of numerous cytoplasmic proteins containing either SH2 or PTB motifs, and activation of protein phosphorylation cascades (eg, Ras-Raf-MAP kinase or PI-3 kinase). Activation of these cascades, in turn, effect gene expression, cellular proliferation and survival, and changes in cell shape, adhesion, and motility. 5, 6 Consequently, EGFR plays an important role in normal cellular proliferation, survival, and differentiation. 7, 8 In addition to the full-length EGFR, cells synthesize ‘‘soluble’’isoforms of EGFR (soluble epidermal growth factor receptor; sEGFR) by alternative mRNA processing. These sEGFR isoforms contain only elements of the extracellular domain and, therefore, are secreted. Alternative EGFR transcripts